1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. CURIS INC

Curis Inc

XNAS: CRIS

Download real time

1.31 0.02 (1.55%)

92.29% Fall from 52W High

75,450 XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
11S
11W
1O
2T
13.7

Market Cap

Low in industry
-0.3

PE TTM

Negative PE TTM
0

PEG TTM

-2.3

Price to Book

Negative Price to Book
0.1

Beta 1Year

Very Low volatility


Insider Trading disclosures for Curis Inc

The latest disclosure was made by James E. Dentzer in Curis Inc where a trade of 40,000 Employee stock option (right to buy) done was reported to US exchanges on Jan. 28, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
James E. Dentzer Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 40,000 40,000 - - Employee stock option (right to buy)
Kenneth I. Kaitin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 1,600 1,600 - - Non Qualified Stock Option
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 1,600 1,600 - - Non Qualified Stock Option
Martyn D. Greenacre Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 1,600 1,600 - - Non Qualified Stock Option
John A. Hohneker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 1,600 1,600 - - Non Qualified Stock Option
Diantha Duvall CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 15,000 15,000 - - Employee stock option (right to buy)
Jonathan B. Zung CDO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 15,000 15,000 - - Employee stock option (right to buy)
James E. Dentzer Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 100,000 100,000 - - Employee stock option (right to buy)
Kenneth I. Kaitin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 4,250 4,250 - - Non Qualified Stock Option
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 4,250 4,250 - - Non Qualified Stock Option
Martyn D. Greenacre Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 4,250 4,250 - - Non Qualified Stock Option
John A. Hohneker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 4,250 4,250 - - Non Qualified Stock Option
Diantha Duvall CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 39,000 39,000 - - Employee stock option (right to buy)
Jonathan B. Zung CDO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 40,700 40,700 - - Employee stock option (right to buy)
Kenneth I. Kaitin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2023 85,000 85,000 - - Non Qualified Stock Option
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2023 85,000 85,000 - - Non Qualified Stock Option
Martyn D. Greenacre Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2023 85,000 85,000 - - Non Qualified Stock Option
John A. Hohneker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2023 85,000 85,000 - - Non Qualified Stock Option
James E. Dentzer Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 1,000,000 1,000,000 - - Employee stock option (right to buy)
Robert E. Martell Head of Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 350,000 350,000 - - Employee stock option (right to buy)
Diantha Duvall CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 500,000 500,000 - - Employee stock option (right to buy)
Kenneth I. Kaitin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 85,000 85,000 - - Non Qualified Stock Option
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 85,000 85,000 - - Non Qualified Stock Option
Martyn D. Greenacre Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 85,000 85,000 - - Non Qualified Stock Option
Lori Anne Kunkel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 85,000 85,000 - - Non Qualified Stock Option
John A. Hohneker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 85,000 85,000 - - Non Qualified Stock Option
Robert E. Martell Head of Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2022 252,000 252,000 - - Employee stock option (right to buy)
William E. Steinkrauss Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2022 360,000 360,000 - - Employee stock option (right to buy)
James E. Dentzer Director, President & CEO Sale of securities on an exchange or to another person at price $ 3.07 per share. 27 Jan 2022 3,094 64,877 (0%) 0% 3.1 9,499 Common Stock
James E. Dentzer Director, President & CEO Sale of securities on an exchange or to another person at price $ 3.18 per share. 27 Jan 2022 2,406 67,971 (0%) 0% 3.2 7,651 Common Stock
James E. Dentzer Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2022 825,000 825,000 - - Employee stock option (right to buy)
James E. Dentzer Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 330,000 330,000 - - Employee stock option (right to buy)
Kenneth I. Kaitin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 33,000 33,000 - - Non Qualified Stock Option
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 33,000 33,000 - - Non Qualified Stock Option
Martyn D. Greenacre Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 33,000 33,000 - - Non Qualified Stock Option
Robert Martell Head of Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 126,000 126,000 - - Employee stock option (right to buy)
Lori Anne Kunkel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 33,000 33,000 - - Non Qualified Stock Option
William Steinkrauss Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 180,000 180,000 - - Employee stock option (right to buy)
James E. Dentzer Director, President & CEO Sale of securities on an exchange or to another person at price $ 10.96 per share. 25 Jan 2021 2,283 70,362 (0%) 0% 11.0 25,022 Common Stock
James E. Dentzer Director, President & CEO Sale of securities on an exchange or to another person at price $ 10.59 per share. 25 Jan 2021 3,094 67,268 (0%) 0% 10.6 32,758 Common Stock
James E. Dentzer Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2020 750,000 750,000 - - Employee stock option (right to buy)
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2020 180,000 180,000 - - Non Qualified Stock Option
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2020 180,000 180,000 - - Non Qualified Stock Option
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2020 180,000 180,000 - - Non Qualified Stock Option
Robert Martell Head of Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2020 385,000 385,000 - - Employee stock option (right to buy)
Lori Anne Kunkel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2020 180,000 180,000 - - Non Qualified Stock Option
William Steinkrauss Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2020 385,000 385,000 - - Employee stock option (right to buy)
Mark W. Noel Vice-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2020 22,632 22,632 - - Non-qualified stock option (right to buy)
Mark W. Noel Vice-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2020 37,368 37,368 - - Qualified stock option (right to buy)
James E. Dentzer Director, President & CEO Sale of securities on an exchange or to another person at price $ 1.69 per share. 23 Jan 2020 3,658 45,252 (0%) 0% 1.7 6,182 Common Stock
James E. Dentzer Director, President & CEO Sale of securities on an exchange or to another person at price $ 1.64 per share. 23 Jan 2020 3,094 42,158 (0%) 0% 1.6 5,076 Common Stock
William Steinkrauss Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Sep 2019 125,000 125,000 - - Employee stock option (right to buy)
James E. Dentzer Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2019 1,115,871 1,115,871 - - Employee stock option (right to buy)
Robert Martell Head of Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2019 386,996 386,996 - - Employee stock option (right to buy)
James E. Dentzer Director, President & CEO Sale of securities on an exchange or to another person at price $ 1.09 per share. 23 Jan 2019 2,397 44,733 (0%) 0% 1.1 2,613 Common Stock
James E. Dentzer Director, President & CEO Sale of securities on an exchange or to another person at price $ 1.16 per share. 23 Jan 2019 3,094 41,639 (0%) 0% 1.2 3,577 Common Stock
Kenneth I. Kaitin None Sale of securities on an exchange or to another person at price $ 1.05 per share. 23 Jan 2019 14,800 28,121 (0%) 0% 1.1 15,587 Common Stock
Marc Rubin None Sale of securities on an exchange or to another person at price $ 1.05 per share. 23 Jan 2019 18,500 28,819 (0%) 0% 1.1 19,477 Common Stock
Martyn D. Greenacre None Sale of securities on an exchange or to another person at price $ 1.05 per share. 23 Jan 2019 18,500 26,089 (0%) 0% 1.1 19,475 Common Stock
Robert Martell Head of Research & Development Sale of securities on an exchange or to another person at price $ 1.07 per share. 23 Jan 2019 5,500 23,027 (0%) 0% 1.1 5,900 Common Stock
Robert Martell Head of Research & Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.07 per share. 23 Jan 2019 8,473 28,527 (0%) 0% 1.1 9,066 Common Stock
Lori Anne Kunkel None Sale of securities on an exchange or to another person at price $ 1.05 per share. 23 Jan 2019 14,800 22,200 (0%) 0% 1.1 15,581 Common Stock
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2019 180,000 180,000 - - Non Qualified Stock Option
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2019 180,000 180,000 - - Non Qualified Stock Option
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2019 180,000 180,000 - - Non Qualified Stock Option
Lori Anne Kunkel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2019 180,000 180,000 - - Non Qualified Stock Option
James E. Dentzer Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2018 750,000 750,000 - - Employee stock option (right to buy)
Robert Martell Head of Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2018 303,000 303,000 - - Employee stock option (right to buy)
James E. Dentzer COO & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2018 825,000 825,000 - - Employee stock option (right to buy)
Ali Fattaey Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2018 825,000 825,000 - - Employee stock option (right to buy)
David Tuck Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2018 535,000 535,000 - - Employee stock option (right to buy)
James E. Dentzer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 206,250 212,011 (0%) 0% 0 Common stock
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 185,000 214,607 (0%) 0% 0 Common stock
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 185,000 236,596 (0%) 0% 0 Common stock
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 185,000 222,945 (0%) 0% 0 Common stock
Robert Martell None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 185,000 185,000 (0%) 0% 0 Common stock
Lori Anne Kunkel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 185,000 185,000 (0%) 0% 0 Common stock
Ali Fattaey Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 206,250 322,140 (0%) 0% 0 Common stock
David Tuck Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 133,750 169,424 (0%) 0% 0 Common stock
Marc Rubin None Purchase of securities on an exchange or from another person at price $ 0.98 per share. 16 Nov 2017 25,000 51,596 (0%) 0% 1.0 24,500 Common Stock
Ali Fattaey Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.06 per share. 15 Nov 2017 50,000 115,890 (0%) 0% 1.1 53,000 Common Stock
Kenneth I. Kaitin None Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.71 per share. 31 May 2017 12,193 29,607 (0%) 0% 1.7 20,850 Common Stock
Kenneth I. Kaitin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 May 2017 5,000 0 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. 31 May 2017 5,000 41,800 (0%) 0% 1.4 6,950 Common Stock
Kenneth I. Kaitin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. 31 May 2017 10,000 36,800 (0%) 0% 1.4 13,900 Common Stock
Kenneth I. Kaitin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 May 2017 10,000 0 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 May 2017 10,000 0 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.71 per share. 31 May 2017 12,193 37,945 (0%) 0% 1.7 20,850 Common Stock
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. 31 May 2017 5,000 50,138 (0%) 0% 1.4 6,950 Common Stock
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. 31 May 2017 10,000 45,138 (0%) 0% 1.4 13,900 Common Stock
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 May 2017 5,000 0 - - Non-qualified stock option (right to buy)
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 1.97 per share. 03 May 2017 30,100 66,176 (0%) 0% 2.0 59,159 Common Stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 1.90 per share. 03 May 2017 16,176 50,000 (0%) 0% 1.9 30,721 Common Stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 2.18 per share. 03 May 2017 30,000 96,276 (0%) 0% 2.2 65,544 Common Stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 2.38 per share. 28 Apr 2017 38,113 161,922 (0%) 0% 2.4 90,709 Common Stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 2.31 per share. 28 Apr 2017 35,646 126,276 (0%) 0% 2.3 82,314 Common Stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 2.45 per share. 28 Apr 2017 42,949 200,035 (0%) 0% 2.4 105,015 Common Stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 2.60 per share. 25 Apr 2017 56,940 912,426 (0%) 0% 2.6 148,306 Common Stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 2.65 per share. 25 Apr 2017 32,738 879,688 (0%) 0% 2.6 86,648 Common Stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 2.65 per share. 25 Apr 2017 19,814 280,186 (0%) 0% 2.6 52,442 Common Stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 2.57 per share. 25 Apr 2017 37,202 242,984 (0%) 0% 2.6 95,624 Common Stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 2.58 per share. 20 Apr 2017 45,705 1,011,442 (0%) 0% 2.6 117,841 Common Stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 2.56 per share. 20 Apr 2017 42,076 969,366 (0%) 0% 2.6 107,862 Common Stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 2.66 per share. 20 Apr 2017 22,541 1,057,147 (0%) 0% 2.7 59,979 Common Stock
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2017 120,000 120,000 - - Non-qualified stock option
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2017 120,000 120,000 - - Non-qualified stock option
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2017 120,000 120,000 - - Non-qualified stock option
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2017 120,000 120,000 - - Non-qualified stock option
Robert Martell None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2017 120,000 120,000 - - Non-qualified stock option
Kenneth J. Pienta None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2017 120,000 120,000 - - Non-qualified stock option
Lori Anne Kunkel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2017 120,000 120,000 - - Non-qualified stock option
James E. Dentzer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2017 650,000 650,000 - - Employee stock option (right to buy)
Ali Fattaey Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2017 1,000,000 1,000,000 - - Employee stock option (right to buy)
Mani Mohindru Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2017 424,000 424,000 - - Employee stock option (right to buy)
David Tuck Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2017 534,000 534,000 - - Employee stock option (right to buy)
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 May 2016 5,000 40,183 - - Common Stock
Martyn D. Greenacre None Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 May 2016 5,000 35,183 - - Common Stock
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 May 2016 10,000 0 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 May 2016 10,000 35,183 - - Common Stock
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 May 2016 5,000 0 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 May 2016 10,000 45,183 - - Common Stock
Kenneth I. Kaitin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 May 2016 5,000 31,800 - - Common Stock
Kenneth I. Kaitin None Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 May 2016 5,000 26,800 - - Common Stock
Kenneth I. Kaitin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 May 2016 10,000 0 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 May 2016 10,000 26,800 - - Common Stock
Kenneth I. Kaitin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 May 2016 5,000 0 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 May 2016 10,000 36,800 - - Common Stock
James E. Dentzer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2016 1,700,000 1,700,000 - - Employee stock option (right to buy)
Mani Mohindru Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2016 200,000 200,000 - - Employee stock option (right to buy)
David Tuck Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2016 300,000 300,000 - - Employee stock option (right to buy)
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2016 50,000 50,000 - - Non-qualified stock option
Daniel R. Passeri None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2016 50,000 50,000 - - Non-qualified stock option
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2016 170,000 170,000 - - Non-qualified stock option
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2016 50,000 50,000 - - Non-qualified stock option
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2016 50,000 50,000 - - Non-qualified stock option
Robert Martell None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2016 50,000 50,000 - - Non-qualified stock option
Kenneth J. Pienta None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2016 50,000 50,000 - - Non-qualified stock option
Ali Fattaey Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2016 1,000,000 1,000,000 - - Employee stock option (right to buy)
Mani Mohindru Sr. VP, Corp. Strategy & IR Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2016 100,000 100,000 - - Employee stock option (right to buy)
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jan 2016 12,900 0 - - Employee stock option
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jan 2016 12,900 211,798 - - Common stock
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Dec 2015 11,200 0 - - Employee stock option
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Dec 2015 14,400 0 - - Employee stock option
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Dec 2015 11,200 210,098 - - Common stock
Daniel R. Passeri None Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Dec 2015 11,200 198,898 - - Common stock
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Dec 2015 14,400 213,298 - - Common stock
Daniel R. Passeri None Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Dec 2015 14,400 198,898 - - Common stock
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Dec 2015 2,600 0 - - Employee stock option
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Dec 2015 11,000 0 - - Employee stock option
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Dec 2015 2,600 201,498 - - Common stock
Daniel R. Passeri None Sale of securities on an exchange or to another person at price $ 0.00 per share. 24 Dec 2015 2,600 198,898 - - Common stock
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Dec 2015 11,000 209,898 - - Common stock
Daniel R. Passeri None Sale of securities on an exchange or to another person at price $ 0.00 per share. 24 Dec 2015 11,000 198,898 - - Common stock
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Dec 2015 38,000 0 - - Employee stock option
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Dec 2015 10,900 0 - - Employee stock option
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Dec 2015 38,000 236,898 - - Common stock
Daniel R. Passeri None Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Dec 2015 38,000 198,898 - - Common stock
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Dec 2015 10,900 209,798 - - Common stock
Daniel R. Passeri None Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Dec 2015 10,900 198,898 - - Common stock
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Dec 2015 189,000 0 - - Employee stock option
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Dec 2015 100,000 0 - - Employee stock option
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Dec 2015 189,000 387,898 - - Common stock
Daniel R. Passeri None Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Dec 2015 189,000 198,898 - - Common stock
Daniel R. Passeri None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Dec 2015 100,000 298,898 - - Common stock
Daniel R. Passeri None Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Dec 2015 100,000 198,898 - - Common stock
Michael Gray CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2015 80,000 80,000 - - Employee stock option (right to buy)
Ali Fattaey Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2015 900,000 900,000 - - Employee stock option (right to buy)
Jaye Viner Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2015 80,000 80,000 - - Employee stock option (right to buy)
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2015 25,000 25,000 - - Non-qualified stock option (right to buy)
Daniel R. Passeri None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2015 25,000 25,000 - - Non-qualified stock option (right to buy)
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2015 85,000 85,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2015 25,000 25,000 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2015 25,000 25,000 - - Non-qualified stock option (right to buy)
Michael Gray CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2015 100,000 100,000 - - Employee stock option (right to buy)
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2015 25,000 25,000 - - Non-qualified stock option (right to buy)
Robert Martell None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2015 25,000 25,000 - - Non-qualified stock option (right to buy)
Kenneth J. Pienta None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2015 25,000 25,000 - - Non-qualified stock option (right to buy)
Ali Fattaey Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2015 100,000 100,000 - - Employee stock option (right to buy)
Jaye Viner Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2015 100,000 100,000 - - Employee stock option (right to buy)
Ali Fattaey Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Aug 2014 62,890 65,890 - - Common stock
Ali Fattaey Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2014 200,000 200,000 - - Employee stock option (right to buy)
Ali Fattaey Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2014 400,000 600,000 - - Nonqualified stock option (right to buy)
James R. Mcnab None Gift of securities by or to the insider at price $ 0.00 per share. 02 Apr 2014 30,000 1,049,688 - - Common stock
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2014 100,000 100,000 - - Employee stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2014 200,000 300,000 - - Non-qualified stock option (right to buy)
Michael Gray CBO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2014 60,000 60,000 - - Employee stock option (right to buy)
Michael Gray CBO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2014 120,000 180,000 - - Non-qualified stock option (right to buy)
Ali Fattaey President & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2014 100,000 100,000 - - Employee stock option (right to buy)
Ali Fattaey President & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2014 200,000 300,000 - - Nonqualified stock option (right to buy)
Jaye Viner Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2014 60,000 60,000 - - Employee Stock Option (right to buy)
Jaye Viner Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2014 120,000 180,000 - - Nonqualified Stock Option (right to buy)
Jaye Viner Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2014 60,000 60,000 - - Employee Stock Option (right to buy)
Jaye Viner Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2014 120,000 180,000 - - Nonqualified Stock Option (right to buy)
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2014 25,000 25,000 - - Non-qualified stock option (right to buy)
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2014 85,000 85,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2014 25,000 25,000 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2014 25,000 25,000 - - Non-qualified stock option (right to buy)
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2014 25,000 25,000 - - Non-qualified stock option (right to buy)
Robert Martell None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2014 25,000 25,000 - - Non-qualified stock option (right to buy)
Kenneth J. Pienta None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2014 25,000 25,000 - - Non-qualified stock option (right to buy)
Ali Fattaey President & COO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 11 Dec 2013 3,000 3,000 - - Common stock
Michael Gray CFO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Nov 2013 10,000 107,304 - - Common stock
Kenneth J. Pienta None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 08 Nov 2013 20,000 30,000 - - Common stock
Kenneth J. Pienta None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Sep 2013 10,000 10,000 - - Common stock
Jaye Viner Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2013 277,680 277,680 - - Qualified Stock Option (right to buy)
Jaye Viner Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2013 97,320 97,320 - - Nonqualified Stock Option (right to buy)
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Aug 2013 50,000 250,000 - - Common stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Aug 2013 50,000 50,000 - - Common stock
Michael Gray CFO Gift of securities by or to the insider at price $ 0.00 per share. 21 May 2013 6,000 97,304 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2013 86,852 285,750 - - Common stock
Daniel R. Passeri CEO and Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 May 2013 100,000 238,898 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2013 188,148 338,898 - - Common stock
Daniel R. Passeri CEO and Director Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 May 2013 40,000 198,898 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2013 51,215 0 - - Incentive stock option
Daniel R. Passeri CEO and Director Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 May 2013 86,852 198,898 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2013 86,852 0 - - Non-qualified stock option
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2013 136,933 86,852 - - Non-qualified stock option
James R. Tobin None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 06 May 2013 41,830 144,921 - - Common stock
James R. Tobin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 May 2013 62,500 0 - - Non-qualified stock option
James R. Tobin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 May 2013 62,500 186,751 - - Common stock
Michael Gray CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 May 2013 49,758 136,371 - - Common stock
Michael Gray CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 May 2013 242 103,304 - - Common stock
Michael Gray CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 May 2013 242 0 - - Non-qualified stock option (right to buy)
Michael Gray CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 06 May 2013 33,309 103,062 - - Common stock
Michael Gray CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 May 2013 49,758 0 - - Qualified stock option (right to buy)
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2013 60,000 95,138 - - Common stock
Martyn D. Greenacre None Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 May 2013 60,000 35,138 - - Common stock
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2013 60,000 0 - - Non-qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 May 2013 65,000 150,750 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2013 65,000 215,750 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2013 50,000 200,750 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2013 60,000 223,785 - - Non-qualified stock option
Daniel R. Passeri CEO and Director Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 May 2013 50,000 150,750 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2013 65,000 283,785 - - Non-qualified stock option
Daniel R. Passeri CEO and Director Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 May 2013 60,000 150,750 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2013 60,000 210,750 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2013 50,000 348,785 - - Non-qualified stock option
Mark W. Noel VP, Tech Management Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2013 17,742 45,282 - - Common stock
Mark W. Noel VP, Tech Management Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2013 52,258 79,798 - - Common stock
Mark W. Noel VP, Tech Management Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2013 52,258 0 - - Qualified stock option (right to buy)
Mark W. Noel VP, Tech Management Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2013 17,742 0 - - Nonqualified stock option (right to buy)
Mark W. Noel VP, Tech Management Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 May 2013 52,258 27,540 - - Common stock
Mark W. Noel VP, Tech Management Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 May 2013 17,742 27,540 - - Common stock
Kenneth J. Pienta None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2013 25,000 25,000 - - Non-qualified stock option (right to buy)
Ali Fattaey President & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2013 124,336 124,336 - - Qualified stock option (right to buy)
Ali Fattaey President & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2013 275,664 400,000 - - Nonqualified stock option (right to buy)
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 25,000 25,000 - - Non-qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 12,501 12,501 - - Qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 187,499 187,499 - - Non-qualified stock option (right to buy)
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 85,000 85,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 25,000 25,000 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 25,000 25,000 - - Non-qualified stock option (right to buy)
Mark W. Noel VP, Tech Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 19,213 19,213 - - Qualified stock option (right to buy)
Mark W. Noel VP, Tech Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 40,787 40,787 - - Non-qualified stock option (right to buy)
Susan B. Bayh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 25,000 25,000 - - Non-qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 16,660 16,660 - - Qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 108,340 108,340 - - Non-qualified stock option (right to buy)
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 25,000 25,000 - - Non-qualified stock option (right to buy)
Robert Martell None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 25,000 25,000 - - Non-qualified stock option (right to buy)
Maurizio Voi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 95,576 95,576 - - Qualified stock option (right to buy)
Maurizio Voi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 29,424 29,424 - - Non-qualified stock option (right to buy)
James R. Mcnab None Gift of securities by or to the insider at price $ 0.00 per share. 20 Dec 2012 30,975 100,000 - - Common stock
Daniel R. Passeri CEO and Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Dec 2012 25,000 150,750 - - Common stock
Michael Gray COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2012 26,250 0 - - Qualified stock option (right to buy)
Michael Gray COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2012 26,250 112,863 - - Common stock
Michael Gray COO and CFO Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Sep 2012 26,250 86,613 - - Common stock
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Sep 2012 50,000 0 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Sep 2012 50,000 85,138 - - Common stock
Martyn D. Greenacre None Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Sep 2012 50,000 35,138 - - Common stock
Mark W. Noel VP, Tech Management Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2012 48,000 0 - - Qualified stock option (right to buy)
Mark W. Noel VP, Tech Management Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2012 48,000 75,540 - - Common stock
Mark W. Noel VP, Tech Management Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Aug 2012 48,000 27,540 - - Common stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Jun 2012 11,000 1,368,688 - - Common stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Jun 2012 150,000 1,218,688 - - Common stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Jun 2012 139,000 1,079,688 - - Common stock
Mark W. Noel VP, Tech Management Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2012 36,413 0 - - Qualified stock option (right to buy)
Mark W. Noel VP, Tech Management Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2012 37,687 0 - - Non-qualified stock option (right to buy)
Mark W. Noel VP, Tech Management Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2012 36,413 63,953 - - Common stock
Mark W. Noel VP, Tech Management Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 May 2012 36,413 27,540 - - Common stock
Mark W. Noel VP, Tech Management Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2012 37,687 65,227 - - Common stock
Mark W. Noel VP, Tech Management Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 May 2012 37,687 27,540 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2012 57,837 0 - - Non-qualified stock option
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2012 16,813 0 - - Non-qualified stock option
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2012 36,000 0 - - Non-qualified stock option
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2012 57,837 183,587 - - Common stock
Daniel R. Passeri CEO and Director Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Apr 2012 57,837 125,750 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2012 16,813 142,563 - - Common stock
Daniel R. Passeri CEO and Director Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Apr 2012 16,813 125,750 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2012 36,000 161,750 - - Common stock
Daniel R. Passeri CEO and Director Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Apr 2012 36,000 125,750 - - Common stock
Michael Gray COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Apr 2012 40,330 0 - - Qualified stock option (right to buy)
Michael Gray COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Apr 2012 93 0 - - Non-qualified stock option (right to buy)
Michael Gray COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Apr 2012 2,421 0 - - Qualified stock option (right to buy)
Michael Gray COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Apr 2012 40,423 127,036 - - Common stock
Michael Gray COO and CFO Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Apr 2012 40,423 86,613 - - Common stock
Michael Gray COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Apr 2012 2,421 89,034 - - Common stock
Michael Gray COO and CFO Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Apr 2012 2,421 86,613 - - Common stock
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Mar 2012 75,000 0 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Mar 2012 5,000 0 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Mar 2012 75,000 110,138 - - Common stock
Martyn D. Greenacre None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Mar 2012 5,000 115,138 - - Common stock
Martyn D. Greenacre None Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Mar 2012 80,000 35,138 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Mar 2012 37,313 0 - - Qualified stock option
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Mar 2012 23,437 0 - - Qualified stock option
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Mar 2012 37,313 102,313 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Mar 2012 23,437 125,750 - - Common stock
James R. Tobin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2012 75,000 0 - - Non-qualified stock option
James R. Tobin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2012 2,500 0 - - Non-qualified stock option
James R. Tobin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2012 75,000 121,751 - - Common stock
James R. Tobin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2012 2,500 124,251 - - Common stock
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2012 85,000 0 - - Non-qualified stock option (right to buy)
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2012 87,500 0 - - Non-qualified stock option (right to buy)
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2012 85,000 0 - - Non-qualified stock option (right to buy)
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2012 85,000 0 - - Common stock
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2012 87,500 0 - - Common stock
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2012 85,000 1,379,688 - - Common stock
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 50,000 25,000 - - Non-qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 38,301 38,301 - - Qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 361,699 361,699 - - Non-qualified stock option (right to buy)
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 170,000 85,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 50,000 25,000 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 50,000 25,000 - - Non-qualified stock option (right to buy)
Mark W. Noel VP, Tech Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 44,450 44,450 - - Qualified stock option (right to buy)
Mark W. Noel VP, Tech Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 35,550 35,550 - - Non-qualified stock option (right to buy)
Susan B. Bayh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 50,000 25,000 - - Non-qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 37,367 37,367 - - Qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 212,633 212,633 - - Non-qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 37,367 37,367 - - Qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 212,633 212,633 - - Non-qualified stock option (right to buy)
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 50,000 25,000 - - Non-qualified stock option (right to buy)
Robert Martell None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 50,000 25,000 - - Non-qualified stock option (right to buy)
Maurizio Voi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 93,750 93,750 - - Non-qualified stock option (right to buy)
Maurizio Voi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 6,250 6,250 - - Qualified stock option (right to buy)
Susan B. Bayh None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2011 18,750 0 - - Non-qualified stock options (right to buy)
Susan B. Bayh None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2011 10,955 0 - - Non-qualified stock options (right to buy)
Susan B. Bayh None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2011 18,750 43,750 - - Common stock
Susan B. Bayh None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2011 10,955 54,705 - - Common stock
Susan B. Bayh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Dec 2011 29,705 25,000 - - Common stock
Maurizio Voi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2011 243,620 243,620 - - Non-qualified stock option (right to buy)
Maurizio Voi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2011 106,380 350,000 - - Qualified stock option (right to buy)
Robert Martell None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Sep 2011 25,000 25,000 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 11 May 2011 6,800 26,800 - - Common stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 0.00 per share. 31 Mar 2011 25,000 1,122,188 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Mar 2011 15,631 0 - - Qualified stock option
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Mar 2011 11,269 98,100 - - Non-qualified stock option
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Mar 2011 98,100 0 - - Non-qualified stock option
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Mar 2011 26,900 91,900 - - Common stock
Daniel R. Passeri CEO and Director Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Mar 2011 26,900 65,000 - - Common stock
Daniel R. Passeri CEO and Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Mar 2011 98,100 163,100 - - Common stock
Daniel R. Passeri CEO and Director Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Mar 2011 98,100 65,000 - - Common stock
James R. Tobin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Mar 2011 12,500 0 - - Non-qualified stock option
James R. Tobin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Mar 2011 12,500 58,738 - - Common stock
James R. Tobin None Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Mar 2011 11,987 46,751 - - Common stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Mar 2011 25,000 1,172,188 - - Common stock
James R. Mcnab None Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Mar 2011 25,000 1,147,188 - - Common stock
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2011 95,000 0 - - Non-qualified stock option (right to buy)
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2011 60,000 0 - - Non-qualified stock option (right to buy)
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2011 90,000 0 - - Non-qualified stock option (right to buy)
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2011 90,000 0 - - Non-qualified stock option (right to buy)
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2011 62,500 0 - - Non-qualified stock option (right to buy)
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2011 95,000 0 - - Common stock
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2011 60,000 0 - - Common stock
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2011 90,000 0 - - Common stock
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2011 90,000 0 - - Common stock
James R. Mcnab None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2011 62,500 1,197,188 - - Common stock
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 25,000 25,000 - - Non-qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 92,324 92,324 - - Qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 107,676 107,676 - - Non-qualified stock option (right to buy)
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 85,000 85,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 25,000 25,000 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 25,000 25,000 - - Non-qualified stock option (right to buy)
Mark W. Noel VP, Tech Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 60,000 60,000 - - Qualified stock option (right to buy)
Susan B. Bayh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 25,000 25,000 - - Non-qualified stock option (right to buy)
Joseph M. Davie None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 25,000 25,000 - - Non-qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 93,492 93,492 - - Qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 31,508 31,508 - - Non-qualified stock option (right to buy)
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 25,000 25,000 - - Non-qualified stock option (right to buy)
Changgeng Qian VP, Research & Preclinical Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 93,492 93,492 - - Qualified stock option (right to buy)
Changgeng Qian VP, Research & Preclinical Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 31,508 31,508 - - Non-qualified stock option (right to buy)
Mitchell Keegan Vice-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 30,254 30,254 - - Qualified stock option (right to buy)
Mitchell Keegan Vice-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 29,746 29,746 - - Non-qualified stock option (right to buy)
Marc Rubin None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Dec 2010 26,596 26,596 - - Common Stock
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 12,500 12,500 - - Non-qualified stock option (right to buy)
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 2,500 15,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 12,500 27,500 - - Non-qualified stock option (right to buy)
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 75,000 102,500 - - Non-qualified stock option (right to buy)
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 2,500 105,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 62,500 167,500 - - Non-qualified stock option (right to buy)
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 2,500 170,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 5,000 175,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 5,000 180,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 7,500 187,500 - - Non-qualified stock option (right to buy)
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 7,500 195,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 7,500 202,500 - - Non-qualified stock option
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 12,500 215,000 - - Non-qualified stock option
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 12,500 227,500 - - Non-qualified stock option
James R. Tobin None Other type of transaction at price $ 0.00 per share. 04 Oct 2010 46,238 46,239 - - Common Stock
Daniel R. Passeri Director, CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Aug 2010 10,000 65,000 - - Common stock
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2010 25,000 25,000 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 25,000 25,000 - - Non-qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 47,714 47,714 - - Qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 152,286 152,286 - - Non-qualified stock option (right to buy)
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 85,000 85,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 25,000 25,000 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 25,000 25,000 - - Non-qualified stock option (right to buy)
Susan B. Bayh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 25,000 25,000 - - Non-qualified stock option (right to buy)
Joseph M. Davie None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 25,000 25,000 - - Non-qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 39,063 39,063 - - Qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 85,937 85,937 - - Non-qualified stock option (right to buy)
Changgeng Qian VP, Research & Preclinical Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 39,063 39,063 - - Qualified stock option (right to buy)
Changgeng Qian VP, Research & Preclinical Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 85,937 85,937 - - Non-qualified stock option (right to buy)
Mitchell Keegan Vice-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 25,283 25,283 - - Qualified stock option (right to buy)
Mitchell Keegan Vice-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2010 34,717 34,717 - - Non-qualified stock option (right to buy)
Mitchell Keegan Vice-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Sep 2009 81,139 81,139 - - Qualified stock option (right to buy)
Mitchell Keegan Vice-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Sep 2009 18,861 18,861 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 7,500 7,500 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 17,500 17,500 - - Non-qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 18,750 18,750 - - Qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 281,250 281,250 - - Non-qualified stock option (right to buy)
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 7,500 7,500 - - Non-qualified stock option
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 87,500 87,500 - - Non-qualified stock option (right to buy)
James R. Tobin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 7,500 7,500 - - Non-qualified stock option (right to buy)
James R. Tobin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 17,500 17,500 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 7,500 7,500 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 17,500 17,500 - - Non-qualified stock option (right to buy)
Mark W. Noel Vice-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 59,199 59,199 - - Qualified stock option (right to buy)
Mark W. Noel Vice-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 15,801 15,801 - - Non-qualified stock option (right to buy)
Susan B. Bayh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 7,500 7,500 - - Non-qualified stock option (right to buy)
Susan B. Bayh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 17,500 17,500 - - Non-qualified stock option (right to buy)
Joseph M. Davie None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 7,500 7,500 - - Non-qualified stock option (right to buy)
Joseph M. Davie None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 17,500 17,500 - - Non-qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 20,210 20,210 - - Qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 159,790 159,790 - - Non-qualified stock option (right to buy)
Changgeng Qian VP, Research & Preclinical Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 20,210 20,210 - - Qualified stock option (right to buy)
Changgeng Qian VP, Research & Preclinical Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 159,790 159,790 - - Non-qualified stock option (right to buy)
Changgeng Qian VP, Research & Preclinical Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 20,210 20,210 - - Qualified stock option (right to buy)
Changgeng Qian VP, Research & Preclinical Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2009 159,790 159,790 - - Non-qualified stock option (right to buy)
Mark W. Noel Vice-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2008 3,579 27,540 - - Common Stock
James R. Mcnab None Gift of securities by or to the insider at price $ 0.00 per share. 30 Dec 2008 25,000 799,688 - - Common stock
Daniel R. Passeri Director, CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Oct 2008 202,000 202,000 - - Non-qualified stock option (right to buy)
Mark W. Noel Vice-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Oct 2008 43,000 43,000 - - Non-qualified stock option (right to buy)
Michael Gray COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Oct 2008 79,113 86,613 - - Common stock
Changgeng Qian VP, Research & Preclinical Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Oct 2008 51,000 51,000 - - Non-qualified stock option (right to buy)
Daniel R. Passeri Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2008 20,000 75,000 - - Common stock
Daniel R. Passeri Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2008 20,000 52,813 - - Non-qualified stock option (right to buy)
Michael Gray COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2008 7,500 26,250 - - Qualified stock option
Michael Gray COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2008 7,500 7,500 - - Common stock
Daniel R. Passeri Director, CEO and Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Aug 2008 20,000 55,000 - - Common stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Aug 2008 50,000 150,000 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 4,743 0 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 1,400 0 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 2,300 0 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 900 0 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 3,300 0 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 3,300 0 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 8,800 0 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 500 0 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 5,200 0 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 15,150 0 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 1,000 0 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 700 0 - - Common Stock
James R. Mcnab None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2008 2,707 874,688 - - Common Stock
Richard H. Aldrich Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Apr 2008 1,300,000 6,250,564 - - Common Stock
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 5,000 5,000 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 10,000 10,000 - - Non-qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 39,554 39,554 - - Qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 260,446 260,446 - - Non-qualified stock option (right to buy)
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 5,000 5,000 - - Non-qualified stock option
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 55,000 55,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 5,000 5,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 10,000 10,000 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 5,000 5,000 - - Non-qualified stock option (right to buy)
Kenneth I. Kaitin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 10,000 10,000 - - Non-qualified stock option (right to buy)
Mark W. Noel VP, Tech Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 52,087 52,087 - - Qualified stock option (right to buy)
Mark W. Noel VP, Tech Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 22,913 22,913 - - Non-qualified stock option (right to buy)
Stephen K. Carter None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 5,000 5,000 - - Non-qualified stock option (right to buy)
Stephen K. Carter None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 10,000 10,000 - - Non-qualified stock option (right to buy)
Susan B. Bayh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 5,000 5,000 - - Non-qualified stock option (right to buy)
Susan B. Bayh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 10,000 10,000 - - Non-qualified stock option (right to buy)
Joseph M. Davie None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 5,000 5,000 - - Non-qualified stock option (right to buy)
Joseph M. Davie None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 10,000 10,000 - - Non-qualified stock option (right to buy)
Michael Gray Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 51,031 51,031 - - Qualified stock option (right to buy)
Michael Gray Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 128,969 128,969 - - Non-qualified stock option (right to buy)
Changgeng Qian VP, Research & Preclinical Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 55,075 55,075 - - Qualified stock option (right to buy)
Changgeng Qian VP, Research & Preclinical Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2008 124,925 124,925 - - Non-qualified stock option (right to buy)
Mark W. Noel VP, Tech Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2007 2,913 0 - - Common Stock
Mark W. Noel VP, Tech Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2007 3,251 23,961 - - Common Stock
Stephen K. Carter None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2007 25,000 25,000 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2007 5,000 5,000 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2007 10,000 10,000 - - Non-qualified stock option (right to buy)
Martyn D. Greenacre None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2007 10,000 35,138 - - Common Stock
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2007 60,836 60,836 - - Qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2007 189,164 189,164 - - Non-qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2007 71,942 71,942 - - Qualified stock option (right to buy)
Daniel R. Passeri CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2007 178,058 178,058 - - Non-qualified stock option (right to buy)
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2007 10,000 824,035 - - Common Stock
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2007 5,000 5,000 - - Non-qualified stock option
James R. Mcnab None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2007 85,000 85,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2007 5,000 5,000 - - Non-qualified stock option (right to buy)
James R. Tobin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2007 10,000 10,000 - - Non-qualified stock option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters